Clinical Trial for Breast Cancer. | Pfizer

A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer.

Closest Location

To find study locations, use the location search box below.

Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition

Breast Cancer

Sex

Male or Female

Age

18+ years

View more eligibility criteria on ClinicalTrials.gov

Study Locations

Location

Distance

University of California San Diego Moores Cancer Center

San Diego, California, United States, 92037

Recruiting

UCLA - Santa Monica Cancer Care

Santa Monica, California, United States, 90404

Recruiting

SCRI Florida Cancer Specialists - Lake Mary

Lake Mary, Florida, United States, 32746

Recruiting

University of Michigan

Ann Arbor, Michigan, United States, 48109

Recruiting

SCRI Tennessee Oncology

Nashville, Tennessee, United States, 37203

Recruiting

Hospital Universitari Dexeus

Barcelona, Spain, 08028

Recruiting

Hospital Ruber Internacional

Madrid, Spain, 28034

Recruiting

Consorci Hospital General Universitari de Valencia

Valencia, Spain, 46018

Recruiting